Health
ErbB inhibitor lapatinib exhibits potent anti-SARS-CoV-2 activity – News-Medical.Net
A team of scientists from the USA and Belgium has recently revealed that the ErbB family of receptor tyrosine kinases play a vital role in regulating severe acute…
A team of scientists from the USA and Belgium has recently revealed that the ErbB family of receptor tyrosine kinases play a vital role in regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lifecycle in host cells and that inhibition of these receptors can protect against SARS-CoV-2-induced acute and chronic lung injuries and inflammation. The study is currently available on the bioRxiv* preprint server.
Background
Since the beginning of the coronavirus disease (COVID-19) pandemic,…
-
Noosa News23 hours agoEnsure voices are heard – Proctor
-
Noosa News18 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business20 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
General24 hours agoReserve Bank board still looking for yesterday’s news